Advanced Pharmaceutical and Medical Device Privacy and Security/Cybersecurity Updates Featured at the 27th Pharma & Device Ethics & Compliance Congress

  • A Hybrid Onsite Conference and Internet Event
  • The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
  • Sponsored by Pharmaceutical Compliance Forum
  • October 13-16, 2026
  • Washington Hilton, Washington, DC
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
INDIVIDUAL AND GROUP REGISTRATION
Register by September 18 for Early Bird
Click here to register individuals or groups.

HILTON GROUP GUEST ROOM DISCOUNT ENDS ON 9/3
Click here for Group Rate of
$289 until Thursday 9/3.

UPDATED AGENDA
Click here for Agenda.

FEATURING AN ADVANCED PHARMA & MED DEVICE PRIVACY & SECURITY/CYBERSECURITY UPDATE BY


WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 24, 2026: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.


THE 2026 27TH ANNUAL CONGRESS FEATURES
  • New half-day Focused Sessions on the afternoon of Tuesday 10/13
  • Over 50 concurrent mini summits and 15 plenary session presentations
  • The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
  • The Industry-only Compliance Best Practices Think Tank hosted by PCF
  • A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
  • Numerous professional networking opportunities

FEATURING C-SUITE CONGRESS VIDEO WELCOME BY

Albert Bourla, DVM, PhD
Chairman & CEO, Pfizer; Former Chair, Pharmaceutical Research & Manufacturers of America (PhRMA); Former President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), New York, NY

GOVERNMENT KEYNOTE SPEAKERS

Jacob Foster, JD
Acting Chief, Health Care Fraud Unit, Criminal Division, Fraud Section, US Department of Justice, Washington, DC
Veronika Peleshchuk Fradlin, MPP
Director, Transparency & Data Group, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Washington, DC
Brenna Jenny, JD, MPH
Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US Department of Justice, Washington, DC

Twyla Mosey, PharmD, RPh
Director, Division of Advertising & Promotion Review, US Food and Drug Administration, Washington, DC
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC

THE ANNUAL ADVAMED, BIO & PHRMA UPDATE BY

John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC
Ida Nassar, JD
VP, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US DEA, Washington, DC
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC

A QUI TAM COUNSEL ROUNDTABLE BY

Mary A. Inman, JD
Partner, Whistleblower Partners; Founding Member & Board Chair, Psst.org; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA
Linda Severin, JD
Managing Member, Whistleblower Law Collaborative LLC; Former Assistant US Attorney, Southern District of New York, US DPJ, Boston, MA
Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA

ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi, Bridgewater, NJ
Kaoutar Afif
Manager, Ethics & Compliance, Cardinal Health, Dublin, OH
Brian C. Barry, JD
Vice President, Chief Compliance Officer, Vertex; Former Compliance Officer, US & Canada, EMD Serono, Boston, MA

Allison Benkert, MBA
Sr. Director, Compliance Policies, Training & Investigations, Jazz, Doylestown, PA
Amy Bensten, JD
Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA
Ashley Blackwood
Manager, Lifescience Compliance, MiMedx, Marietta, GA

Brent Boeckmann, MBA
Strategic Advisor, Commercial Immunology, Sanofi; Fmr VP, Eli Lilly - Inproteo Affiliate, Boston, MA
Peter Brensilver, JD
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY
Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Fmr CCO, LivaNova, Summit, NJ

Sri Burra, MBA
Director, US Ethics & Compliance, Organon; Fmr Ethics & Compliance Lead, NA, Haleon, Malvern, PA
Briana Cabrera, MS, CFE
Senior Director, Global Privacy, Medtronic; Fmr Director, Forensic Audit, Covidien, Miami, FL
Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY

Maureen Cawley, JD
Senior Director, Corporate Counsel, Incyte; Fmr Global Agreements Attorney, Merck, Philadelphia, PA
Jessica Constant, MS
Associate Director, Compliance, AstraZeneca; Fmr Global Compliance Business Partner, QIAGEN, Washington, DC
Elizabeth Conti, JD
Senior Legal Counsel, Nestlé Health Science, Arlington, VA

Reetu Dandora, JD
SVP, Quality & Regulatory Compliance, AVEO; Fmr Executive Director Strategic Quality Oversight, Merck, Boston, MA
Giulia Del Cane, MS
Head, E&BI Projects & Compliance Officer, Enabling Functions, Global Specialty Care, Sanofi, Boston, MA
Sharon R. Delshad, JD
Senior Director, Legal-Compliance Counsel, Travere Therapeutics, Del Mar, CA

Jason DiPietro
Senior Manager Compliance Analytics & Transparency Compliance, Lundbeck, Lake Zurich, IL
Colleen Doyle, ACFE
Senior Director, Risk Insights, Novo Nordisk; Fmr Senior Director, Compliance, Sage, Plainsboro, NJ
Jennifer Dubas, JD
CCO, Jazz; Fmr SVP & CCO, Concore; Fmr SVP & CCO, AmerisourceBergen, Ambler, PA

Katherine Dyson, JD
Head of US Compliance, Alexion; Fmr Head of Assurance, Alexion, AstraZeneca, Boston, MS
Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Fmr CCO, Kaleo; Fmr SVP, Boston Scientific, Richmond, VA
Patrice Ettinger, JD, CIPP/US
VP, CPO, Regeneron; Fmr CPO, Pfizer; Fmr CPO, Avon, New York, NY

Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Fmr Senior Director, AGC, Pacira, Morristown, NJ
Susana Franco, MBA
Director, Field Compliance, Lundbeck; Fmr Director, Compliance Operations, Orthofix, Dallas, TX
Rawan Fusisi
Head, Transparency and Third Party Compliance, Indivior; Fmr Transparency and Analytics Manager, Stryker, Washington, DC

Julian Gabbard, JD
Associate GC, Meso Scale; Fmr Head of Legal & Compliance, Kolon; Fmr Sr. Director, Arcellx, Washington, DC
Naveen Ganesh, MA, JD
VP, Global Head of Investigations, Takeda; Fmr Head of Investigations, North America & Global Specialty Care, Sanofi, Boston, MA
Jeanille Gatta, MA
Director, Compliance Business Partner, AstraZeneca, North America, Philadelphia, PA

Edmund Greenidge JD, LLM, CCEP
Senior Director, Compliance, Summit; Former R&D Ethics and Compliance Lead, Takeda; Former VP, Corporate Compliance, Aclaris, Menlo Park, CA
Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Fmr Compliance Director, Meetings & Events International, Deerfield, IL
Jim Gibney
Vice President, Global Compliance Operations, Regeneron; Fmr Director, Worldwide Programs, Pfizer, Ridgewood, NJ

Jillian A. Gillespie, MBA
Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Fmr Director, Compliance Business Partner, Seagen, Chicago, IL
Betania Glorio, JD
SVP & CCO, Avidity; Fmr CCO & Head, Group Compliance & Data Privacy, EMD Serono, Boston, MA
Kate Godfrey, JD, CCEP
SVP, Global Chief Compliance Officer, Karl Storz North America, El Segundo, CA

Kimberly Gold, JD
CPO & Senior AGC, Privacy Law, Genentech; Fmr Privacy Secondee, Pfizer, San Francisco, CA
Michele Guerino, MS
Executive Director, Ethics and Compliance Officer, Merck; Fmr Senior Regional Business Director, Cubist, Hopewell, NJ
Tracey Hannon, JD
Director, Compliance Business Partner, Alexion; Fmr Compliance Counsel, Ionis, Boston, MA

Kathryn Harris, JD
Head, US Compliance, Galderma; Fmr Senior Director, Global Compliance, Emergent, Boston, MA
Laura E. Heyduk
Vice President, Head of Global Compliance, KalVista; Fmr Head, US Compliance, Biogen; Fmr Compliance Director, Insulet, Cambridge, MA
Stefanie L. Hill, JD
Senior Director, Global Ethics & Compliance, Emergent; Fmr Senior Compliance Counsel, Prolacta, Gaithersburg, MD

Tom Hiney, JD
Head, Digital Ethics, US Business Unit, Takeda; Fmr Privacy Counsel, Blueprint, Boston, MA
Marla Izbicky, JD
Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL
Tahvia Jenkins, JD, CIPPUS
US Privacy Officer & Counsel, Sanofi; Fmr Assistant Counsel, University of California, Cambridge, MA

Kathy Johnson, JD
Vice President, Commercial and Development Legal, Vertex; Fmr, US Legal Counsel Consultant, Takeda, Boston, MA
Melissa (Missy) Kaschak, MS, CPA, CFE, CISA
GRC Operations, Olympus Corporations of the Americas, Center Valley, PA
Abe Kassis, MBA, PhD
Global Head Compliance & Legal, Bausch + Lomb; Fmr Global Compliance Director, Takeda, New York, NY

Geeta Kaveti, MHA, JD
CCO & US General Counsel, Nyxoah; Fmr VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Fmr Deputy CCO US, Jazz; Fmr Board Chair, PCF, New York, NY
Peggy Kruk, HMCC
Compliance Manager, MiMedX; Fmr Director, Compliance, Program Services, Vaniam Group, Dallas, GA

Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Fmr VP, ESG Strategy & Execution, BMS; Fmr VP, Compliance Worldwide, Celgene, New York, NY
Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Fmr CCO, Mirati Therapeutics; Fmr CCO, Heron Therapeutics, San Diego, CA
Aaron Lewis, MBA
Director, Legal & Compliance, Cordis; Fmr Director, Compliance Insights, Cardinal Health, Miami Lakes, FL

Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Fmr CCO, Rafael Holdings; Fmr VP, Ethics, Novartis, Tarrytown, NY
Christian Malias, MBA
Assoc. Director, Compliance Program, Insmed; Fmr Assoc. Director Compliance, Sage, Pittsburgh, PA
Danielle Manner, JD
Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Fmr Senior Privacy Counsel, Pfizer, Chicago, IL

Aaron P. Mastery, CPA
Senior Director, Compliance Operations, Mighty; Fmr Director, Compliance Auditing & Monitoring, Idorsia, Wilmington, DE
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Fmr Director, Regulatory-Legal, Merck, Philadelphia, PA
Nick Merker, JD
Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN

Fabiana Morette-Lattea, LLM, LLB
Global Compliance Program Lead, Telix; Fmr Associate Director, Compliance, Merck, Indiana, IN
Michael Morgan, MBA, CCEP
Global Compliance Officer, Telix; Fmr Ethics and Compliance Officer-North America, Corteva, Indianapolis, IN
Michelle Murphy
Executive Director, Compliance, Regeneron; Former Consultant, Musculoskeletal Transplant Foundation, New York, NY

Meghan Naas, MA
Corporate Compliance Officer, Innoviva Specialty Therapeutics; Fmr Head of Corporate Compliance, Adaptimmune, Waltham, MA
Eric Ortman, MBA
Senior Director, Legal Operations Compliance, 4D Molecular; Fmr Senior Director, Legal Operations, BeiGene, Walnut Creek, CA
Alison Page, JD
Assistant General Counsel, Pfizer, New York, NY

Al Park
Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Fmr Global Program Effectiveness, Amgen, Phoenix, AZ
Sandra Park, JD
Senior VP, Legal & CCO, Vera; Fmr GC & CCO, IDEOlogy Health; Fmr VP, Commercial Legal, Kite, Brisbane, CA
Samantha Brabant Philis, CCEP
Director, E&C Policy, Training & Business Operations, Jazz; Fmr Sr Manager, Office of Ethics & Compliance, Medline Industries, Chicago, IL

Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children’s Health System of Texas; Fmr Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX
Lauren Ann Pond, JD
Assistant General Counsel, BridgeBio; Fmr Commercial Counsel, Biogen; Fmr Counsel, Takeda, Palo Alto, CA
Hannah Putnam, MHA
Head of Ethics & Compliance Operations, Oncology, Takeda; Fmr Senior Director, Ethics & Compliance, Veloxis, Cambridge, MA

Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy, ZOLL; Fmr Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain
Omar Richardson, MBA
Executive Director, Compliance, Shionogi; Fmr Compliance Officer, Grünenthal, New York, NY
Roberta Rima, MS
VP, Global Compliance Audit, Monitoring & Analytics, Zimmer Biomet; Fmr Sr Director, Gilead, San Francisco, CA

Megan Roberts, CPA, MS
Head, Integrity & Compliance, Par Health; Fmr Senior Director, Integrity, Mallinckrodt, St. Louis, MO
Jaya Saigal
Senior Director, C&E Policy, Education, Communications, Culture of Integrity and Ombuds, BMS, Princeton, NJ
Monica Schroeter, CPA, CISA
Head of Compliance Operations and Risk, LivaNova; Fmr Head of Compliance & Privacy, SK Life Sciences, Goshen, NY

Christian Scognamillo, JD
Associate GC, US Market Access & Pricing, Abbvie; Fmr Senior Corporate Counsel, Market Access, Exelixis, San Francisco, CA
Alexis Shaw, ACFE
Deputy CCO, Paratek; Fmr Global Compliance Investigations Manager, Boston Scientific, King of Prussia, PA
R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Past Chair, Health Care Compliance Association, Lexington, KY

Jesse Siegel, JD
Head of Business Ethics, Americas, Ipsen; Fmr Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA
Matthew Stasiunas
RAMP & Project Management Lead, Indivior; Fmr Senior Specialist, Integrity & Compliance, Kaléo, Richmond, VA
Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Fmr Sales Leader, Eli Lilly Specialty, Marietta, GA

Kelly J. Tope, JD, MBA
Head, Ethics & Business Integrity Governance, Sanofi; Fmr Head, USBU Ethics & Compliance, Takeda, Boston, MA
Emily Treanor, JD
Head of Global Investigations, Alnylam; Fmr Senior Legal Counsel, Global Compliance, Hess, Washington, DC
Natasha Trifun, JD
Head of Enterprise Compliance & Risk and Privacy, AstraZeneca; Fmr Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA


INDIVIDUAL AND GROUP REGISTRATION
Register by Sep. 18 for Early Bird
Click here to register.
HILTON GROUP GUEST ROOM DISCOUNT ENDS ON 9/3
Click here for Group Rate of
$289 until Thursday 9/3.
UPDATED AGENDA
Click here for Agenda.
SPONSORED BY


PRODUCED BY


PCF BOARD

Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)


Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed


Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline


Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB


Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda


Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron

MEDICAL DEVICE EXECUTIVE COMMITTEE

Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor


JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum


Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical


Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic


Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker

GRANTORS
PLATINUM


GOLD














SILVER

























BRONZE

















































EXHIBITORS




TUITION SCHOLARSHIPS
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.

Akosua Tuffour, JD
Corporate Counsel, U.S. General Medicines, Sanofi, Washington, DC
Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY
Achsah Warren, MSJ
Vice President Compliance, Sumitomo; Fmr Vice President Compliance, Urovant; Fmr Senior Compliance Manager, Allergan, Irvine, CA
Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC
Elizabeth Weiss, JD
VP, Chief Compliance & Privacy Officer, Invivyd; Fmr Head of Compliance for Americas & EMEA, Lupin; Fmr Assistant GC, Pfizer, Livingston, NJ

Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Fmr Head of US Compliance, MorphoSys; Fmr Director, Enterprise Compliance, Alexion, Boston, MA
Suki Wiltman
Vice President, Global Ethics & Compliance, Ipsen; Fmr Business Partner, Governance, Ethics & Compliance, GSK, Toronto, Canada
Katie Winson, MS
Director, Ethics & Compliance Business Partner, Jazz; Fmr Senior Manager, Monitoring, US & Global Compliance, Celgene, Carlsbad, CA
Stacy E. Yeung, JD
VP & GC, SELLAS; Fmr Assistant General Counsel, Arena Pharma; Fmr Deputy General Counsel, DBV Technologies, New York, NY
Olga Zinavenka, CPA, MBA
Head of Compliance Operations, Keenova; Fmr Executive Director, Head of Compliance Operations, Endo, Paoli, PA

FORMER GOVERNMENT OFFICIALS

Corey R. Amundson, JD
Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC
David M. Blank, JD
Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI
Deborah A. Curtis, JD
Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC

Greg Demske, JD
Partner, Goodwin Procter; Fmr Chief Counsel, Office of Inspector General, US HHS, Washington, DC
David J. Derusha, JD
Assistant General Counsel, Vertex; Former Assistant US Attorney, US Attorney’s Offices Office, District of Massachusetts, US Department of Justice, Boston, MA
Edward Diskant, JD
Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Fmr Attorney, US FTC, Washington, DC
Gregory T. Garcia
Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Fmr Assistant Secretary for Cybersecurity, US DHS, Washington, DC

Gejaa T. Gobena, JD
Partner, Hogan Lovells Cadwalader; Fmr Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Christine Gordon, JD
VP, Risk, Assurance, & Compliance and CCO, Olympus; Fmr Assistant District Attorney, Philadelphia DA’s Office, Bethlehem, PA
Adam Greene, JD, MPH
Partner & Co-chair, HIPAA Practice, Davis Wright Tremaine; Fmr Senior HIT & Privacy Specialist, OCR, HHS, Washington, DC
Kristie Gurley, JD
Partner Covington & Burling; Fmr Counsel, Office of the General Counsel, CMS Division, US Department of HHS, Washington, DC
Sarah M. Hall, JD
Partner, Member of the Firm, Epstein Becker Green; Fmr Trial Attorney, Fraud Section, Criminal Division, US DOJ, Washington, DC

Christina Hud, JD
Senior Counsel, Global Investigations, Pfizer; Fmr Health Care Fraud Acting Unit Chief & Senior Trial Counsel, US Attorney’s Office, District of New Jersey, US DOJ, New York, NY
Michelle Jerrett, JD
Regional Head of Investigations & Monitoring, NA, Sanofi; Fmr AUSA, US Attorney's Office, District of Massachusetts, US DOJ, Cambridge, MA
Stewart Kameen, JD
Partner, Davis Wright Tremaine; Fmr Senior Counsel, Industry Guidance Branch, OIG, HHS, Washington, DC
Shannon Kelley, JD
EVP, Chief Legal Officer, Madrigal; Fmr AUSA & Deputy Chief of Litigation, US Attorney's Office District of Massachusetts, Boston, MA
John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Fmr Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

Barbara A. Leaf, JD
Senior Int'l Advisor, Arnold & Porter; Fmr Special Assistant to the President; Fmr US Ambassador, UAE, Washington, DC
Christine Moundas, JD
Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Fmr Analyst, OIG, US HHS, New York, NY
Preeya Noronha Pinto, JD
Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC
Kenneth A. Polite, Jr, JD
Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC
Lisa M Re, JD
Partner, Life Sciences, Arnold & Porter; Fmr Assistant Inspector General for Legal Affairs, OIG, US HHS, Washington, DC

Angela Schwartz, JD
Senior Principal, Global Commercial Compliance Consulting Leader, IQVIA; Fmr Special Assistant District Attorney, Montgomery County DA's Office, Philadelphia, PA
David J. Scott, MS
Managing Director, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA
Diane Seol, JD
Of Counsel, Choate Hall & Stewart; Fmr AUSA, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA
Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ
Amanda Strachan, JD
Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

Julie K. Taitsman, MD, JD
Managing Director, BDO, US; Fmr CMO, HHS OIG; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC
Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY
Heather Young, JD
Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA

COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

Warren T. Allen II, JD
Principal, Miles & Stockbridge, Washington, DC
David Amendola
Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY
Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC
Minna Bak, MBA
Managing Director, HELIO, Boston, MA
Brett Barlag, MBA
Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY
For the complete list of speakers, click here

NEW THIS YEAR: FEATURING 5 IN-DEPTH, HALF-DAY, AFTERNOON
FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13
(Included in your Congress registration.)
Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
  • Explore leading practices for managing hotline complaints, conducting effective internal investigations, assessing whistleblower risk, making escalation decisions, and navigating today's evolving enforcement environment.
  • Featuring a Qui Tam Counsel Roundtable
Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
  • Gain practical insights into the latest privacy, cybersecurity, and data protection developments impacting life sciences organizations, including advanced compliance strategies and emerging regulatory expectations.
  • Featuring Presentations by International Association of Privacy Professionals & International Pharma & Medical Device Privacy Consortium
Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
  • Examine how leading organizations are strengthening collaboration between Medical Affairs and Commercial while maintaining Medical independence, managing evolving field-based roles, and implementing effective governance models.
  • Featuring Have We Become Too Restrictive? Rethinking Medical-Commercial Governance for the Next Era
Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
  • Hear directly from compliance leaders who are using artificial intelligence to enhance monitoring, investigations, policy development, training, and other compliance activities through practical, real-world case studies.
  • Featuring the Health Care Compliance Association Presents: Advanced Strategies in Using AI to Monitor and Improve Compliance
Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today's Evolving Pricing & Contracting Landscape
  • Build a foundational understanding of government pricing while exploring the latest developments affecting pricing, contracting, reimbursement, and compliance in today's rapidly changing regulatory environment.
  • Featuring session on the new world of tariffs, mist favored nations, TrumpRX, Medicare drug price negotiation etc.

CONGRESS REGISTRATION

For Congress registration information, visit www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.


FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.